日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure

复发或难治性急性髓系白血病在menin抑制失败后的预后

Chin, Kuo-Kai; Ball, Brian J; Abaza, Yasmin; Altman, Jessica K; Thakur, Rahul K; Ali, Moiez; Derkach, Andriy; Geyer, Mark B; Goldberg, Aaron D; Haque, Tamanna Z; Thompson, Meghan C; Park, Jae H; Tallman, Martin S; Cai, Sheng F; Wang, Eunice S; Aldoss, Ibrahim T; Stein, Eytan M

Targeted Therapy in Acute Myeloid Leukemia: Current Approaches and Novel Directions

急性髓系白血病靶向治疗:当前方法与新方向

Ko, Kaitlyn H; Gelfer, Rebecca; Wheat, Justin C; Cai, Sheng F

Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML

阿扎胞苷、维奈托克和瑞伐美尼用于新诊断的NPM1突变或KMT2A重排急性髓系白血病

Zeidner, Joshua F; Lin, Tara L; Welkie, Rina Li; Curran, Emily; Koenig, Kristin; Stock, Wendy; Madanat, Yazan F; Swords, Ronan; Baer, Maria R; Blum, William; Stein, Eytan M; Olin, Rebecca L; Schiller, Gary; Nichols, Angela; Odenike, Olatoyosi; Traer, Elie; Lachowiez, Curtis; Duong, Vu H; Hochman, Michael J; Cai, Sheng F; Smith, Catherine; Stefanos, Mona; Martycz, Molly; Huang, Ying; Rosenberg, Len; Marcus, Sonja; Chen, Timothy L; Yocum, Ashley O; Druker, Brian J; Levine, Ross L; Borate, Uma; Byrd, John C; Mims, Alice S

Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia.

对 IDH 突变型急性髓系白血病中的克隆和细胞结构进行解卷积。

Sirenko Maria, Lee Soobeom, Sun Zhengxi, Chaligne Ronan, Loghavi Sanam, Asimomitis Georgios, Brierley Charlotte K, Bernard Elsa, Cai Sheng F, Myers Robert M, Nadorp Bettina, Sango Junya, Lallo Morgan, Levine Max F, Domenico Dylan, Arango Ossa Juan E, Medina-Martinez Juan S, Menghrajani Kamal, Lasry Audrey, Mims Alice S, Desai Helee, Laganson Andrea, Famulare Chris, Patel Minal, Lozanski Gerard, Bolton Kelly L, Viny Aaron D, Roshal Mikhail, Levine Ross L, Papapetrou Eirini P, Stein Eytan M, Landau Dan A, Eisfeld Ann-Kathrin, Aifantis Iannis, Papaemmanuil Elli

PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and monosomy 7

PRC2介导的细胞凋亡逃逸是携带inv(3)/t(3;3)和7号染色体单体的MDS/AML的治疗靶点。

Kunimoto, Hiroyoshi; Miura, Ayaka; Sagisaka, Maiko; Ito, Mieko; Maenosono, Ryoichi; Yamauchi, Hirofumi; Nishimura, Kazuki; Honma, Daisuke; Tsutsumi, Shinji; Adachi, Akiko; Sakuma, Takayuki; Ohashi, Takuma; Teranaka, Hiroshi; Ikeda, Junji; Samukawa, Sei; Toya, Takashi; Harada, Yuka; Doki, Noriko; Cai, Sheng F; Maki, Hiroaki; Goto, Hiroaki; Yoshimi, Akihide; Nakajima, Hideaki

Exercise and Nutrition to Improve Cancer Treatment-Related Outcomes (ENICTO)

运动与营养改善癌症治疗相关结果(ENICTO)

Schmitz, Kathryn H; Brown, Justin C; Irwin, Melinda L; Robien, Kim; Scott, Jessica M; Berger, Nathan A; Caan, Bette; Cercek, Andrea; Crane, Tracy E; Evans, Scott R; Ligibel, Jennifer A; Meyerhardt, Jeffrey A; Agurs-Collins, Tanya; Basen-Engquist, Karen; Bea, Jennifer W; Cai, Sheng F; Cartmel, Brenda; Chinchilli, Vernon M; Demark-Wahnefried, Wendy; Dieli-Conwright, Christina M; DiPietro, Loretta; Doerksen, Shawna E; Edelstein, Sharon L; Elena, Joanne; Evans, William; Ferrucci, Leah M; Foldi, Julia; Freylersythe, Sarah; Furberg, Helena; Jones, Lee W; Levine, Ross; Moskowitz, Chaya S; Owusu, Cynthia; Penedo, Frank; Rabin, Borsika A; Ratner, Elena; Rosenzweig, Margaret; Salz, Talya; Sanft, Tara; Schlumbrecht, Matthew; Spielmann, Guillaume; Thomson, Cynthia A; Tjaden, Ashley H; Weiser, Martin R; Yang, Shengping; Yu, Anthony F; Perna, Frank M

Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs

急性髓系白血病患者在门诊接受阿糖胞苷巩固治疗可安全有效地缩短住院时间和降低治疗成本。

Burton, Hannah; Boussi, Leora; Nemirovsky, David; Derkach, Andriy; Ciervo, Jenna; Famulare, Christopher; Chin, Kuo-Kai; Valtis, Yannis; Yisraeli Salman, Meira; Patel, Kishan; Shah, Gunjan L; Goldberg, Aaron D; Geyer, Mark B; Thompson, Meghan C; Tallman, Martin S; Stein, Eytan M; Cai, Sheng F

scDNA: Single Cell DNA analysis software toolkit for subclonality discovery and assessment

scDNA:用于亚克隆性发现和评估的单细胞DNA分析软件工具包

Bowman, Michael; Gounder, Shreeya; Singh, Varsha; Shestova, Olga; Robinson, Troy; Zhang, Amy; Gandhi, Anushka; Bandopadhyay, Roopsha; Cai, Sheng F; Levine, Ross L; Gill, Saar I; Miles, Linde A; Bowman, Robert L

CRISPR Dependency Screens in Primary Hematopoietic Stem Cells Identify KDM3B as a Genotype-specific Vulnerability in IDH2- and TET2-mutant Cells.

在原代造血干细胞中进行的 CRISPR 依赖性筛选发现 KDM3B 是 IDH2 和 TET2 突变细胞中的基因型特异性脆弱性

Waarts Michael R, Mowla Shoron, Boileau Meaghan, Martinez Benitez Anthony R, Sango Junya, Bagish Maya, Fernández-Maestre Inés, Shan Yufan, Eisman Shira E, Park Young C, Wereski Matthew, Csete Isabelle, O'Connor Kavi, Romero-Vega Angelica C, Miles Linde A, Xiao Wenbin, Wu Xiaodi, Koche Richard P, Armstrong Scott A, Shih Alan H, Papapetrou Eirini P, Butler Jason M, Cai Sheng F, Bowman Robert L, Levine Ross L

Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms

Jak2V617F 可逆激活在骨髓增生性肿瘤中发挥着至关重要的作用

Andrew J Dunbar # ,Robert L Bowman # ,Young C Park ,Kavi O'Connor ,Franco Izzo ,Robert M Myers ,Abdul Karzai ,Zachary Zaroogian ,Won Jun Kim ,Inés Fernández-Maestre ,Michael R Waarts ,Abbas Nazir ,Wenbin Xiao ,Tamara Codilupi ,Max Brodsky ,Mirko Farina ,Louise Cai ,Sheng F Cai ,Benjamin Wang ,Wenbin An ,Julie L Yang ,Shoron Mowla ,Shira E Eisman ,Amritha Varshini Hanasoge Somasundara ,Jacob L Glass ,Tanmay Mishra ,Remie Houston ,Emily Guzzardi ,Anthony R Martinez Benitez ,Aaron D Viny ,Richard P Koche ,Sara C Meyer ,Dan A Landau ,Ross L Levine